Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://covid19.nih.gov/

Principal Investigator
Name
John Cramer
Degrees
M.D.
Institution
Karmanos Cancer Institute
Position Title
Assistant Professor
Email
About this CDAS Project
Study
NLST (Learn more about this study)
Project ID
NLST-714
Initial CDAS Request Approval
Oct 8, 2020
Title
Incidence of Second Primary Lung Cancer in Patients with a History of Head and Neck Cancer
Summary
Patients with a history of head and neck squamous cell carcinoma (HNSCC) are thought to be at an especially high risk of lung cancer.
However there are a paucity of data on HNSCC patients comparing survival with or without low-dose helical computed tomography (LDCT) screening for lung cancer. Our goal is to compare the incidence of second primary lung cancers (SPLCs) in patients with a history of HNSCC with LDCT or chest X-ray screening for lung cancer.
Aims

1. Determine the incidence of second primary lung cancer in patients with a history of head and neck cancer with LDCT or chest X-ray screening for lung cancer.

Collaborators

None